Ruihao Jiang

Ruihao Jiang

Auto-generated profile, based on publicly available information

Ruihao Jiang

The First Affiliated Hospital of Wenzhou Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
WNWeicheng Ni
Weicheng Ni
XCXingxing Chen
Xingxing Chen
KGKun Guo
Kun Guo
QNQingwei Ni
Qingwei Ni
KLKen Lin
Ken Lin
HZHao Zhou
Hao Zhou
Background: Metabolic hyperferritinemia (MHF) is associated with the occurrence and progression of cardiovascular disease. Our aim is to investigate the prevalence of MHF, as defined by the latest consensus, and validate its association with major adverse cardiovascular events (MACEs) in heart failure with preserved ejection fraction with different glucose metabolism conditions. Methods and Results: This retrospective study included 7498 patients with heart failure with preserved ejection fraction, with a median follow‐up duration of 2.5 years. MHF is defined as an elevation in serum ferritin accompanied by metabolic dysfunction, and is categorized into different grades based on ferritin levels. The outcome of the study is MACEs. Among the 7498 patients with heart failure with preserved ejection fraction (with an average age of 70.23±10.85 years; 52.68% male), nearly one third (29.7%) had MHF. The majority of these patients were classified as Grade 1 (21.7%), with Grade 2 accounting for 5.2% and Grade 3 for 2.9%. As the severity of MHF increased, the proportion of patients with abnormal glucose metabolism (prediabetes and diabetes) also increased. Cox regression analysis revealed that, even after full adjustment, MHF Grade 2/3 remained significantly associated with a higher risk of MACEs compared with non‐MHF (hazard ratio [HR], 1.43 [95% CI, 1.26–1.62]). The correlation between MHF and MACEs remained consistent across different glucose metabolism statuses. Conclusions: In the population with heart failure with preserved ejection fraction, the baseline prevalence of MHF is notably high. Furthermore, patients who exhibit higher grades of MHF are at an increased risk of MACEs. Additionally, patients with elevated MHF grades also suffer from higher proportions of diabetes and prediabetes.

1 January 2022 in Digestive Surgery
Verified
Journal Article
Closed access
PDF file
LZLeilei Zhu
Leilei Zhu
JSJingyi Shen
Jingyi Shen
RFRongrong Fu
Rongrong Fu
XLXiaozhen Lu
Xiaozhen Lu
LDLiwen Du
Liwen Du
YSYongwei Shi
Yongwei Shi
Background: Nowadays, minimally invasive intervention (MII) has largely replaced delayed open surgery in acute necrotizing pancreatitis (ANP). However, the timing of MII remains unclear. The present study investigated the effect of early versus delayed MII on complications in ANP. Methods: Studies evaluating the impact of the timing of MII on complications in ANP patients were thoroughly searched on PubMed, Embase, Cochrane Library, and Web of Science from inception to June 2022. The primary outcome of interest was mortality. Secondary outcomes were the incidence of complications. Results: Nine studies reporting 870 patients undergoing MII for ANP were included. No significant difference was found in mortality between the early and delayed intervention groups. In addition, the timing of MII was not associated with the incidence of new-onset respiratory failure, new-onset cardiovascular failure, new-onset renal failure, new-onset multiple organ failure, gastrointestinal fistula or perforation, pancreatic fistula, stent migration, bleeding, venous thrombosis, and new-onset pancreatic endocrine insufficiency. Notably, in the subgroup analysis of biliary and Asian ANP patients, early intervention was associated with a significantly higher risk of new-onset renal failure than delayed intervention. Conclusions: Early intervention is safe and recommended only for patients with indications for intervention, such as infection.

23 October 2026 in JMIR Medical Informatics
Verified
Journal Article
Open access
WFWang Feng
Wang Feng
RJRuihao Jiang
Ruihao Jiang
WHWendi Huang
Wendi Huang
CWChuanpeng Wang
Chuanpeng Wang
ZWZhuoquan Wang
Zhuoquan Wang
XLXi Liu
Xi Liu
Background: Major adverse renal and cardiovascular events (MARCE) have been proposed as a comprehensive end point reflecting both cardiac and renal outcomes in patients with acute myocardial infarction (AMI) and chronic kidney disease (CKD). However, existing prediction tools lack accuracy and generalizability for this high-risk population. Objective: This study aimed to develop and externally validate explainable machine learning models and a nomogram for predicting in-hospital MARCE among patients with AMI and CKD. Methods: We enrolled patients with AMI and CKD who underwent emergency treatment at the First Affiliated Hospital of Wenzhou Medical University as the discovery cohort and those at Wenzhou TCM (traditional Chinese medicine) Hospital of Zhejiang Chinese Medical University as the external validation cohort. Clinical features, including demographic details, comorbidities, laboratory results, echocardiography measurements, procedural details, and medication parameters, were collected for all participants. Important variables were selected using least absolute shrinkage and selection operator regression in the training set. We developed extreme gradient boosting (XGBoost), random forest, decision tree, and logistic regression (LR) models and evaluated their discrimination, calibration, and classification metrics in the hold-out test set and external cohort. Results: In the training set, we identified 6 important variables (Killip class, lactate, estimated glomerular filtration rate, use of diuretics, use of beta-blockers, and use of renin-angiotensin system inhibitors). In the test set, model discrimination was comparable across XGBoost (area under the receiver operating characteristic curve [AUC] 0.882, 95% CI 0.816-0.947), LR (AUC 0.875, 95% CI 0.799-0.950), and random forest (AUC 0.870, 95% CI 0.800-0.940), while decision tree showed lower performance (AUC 0.814, 95% CI 0.720-0.886). Shapley additive explanations (SHAP) values illustrated both global and individual feature contributions in the XGBoost model. A nomogram based on LR achieved an AUC of 0.873 (95% CI 0.714-0.926) in external validation. Conclusions: Our study identified 6 important predictors and provided a series of prediction models to enhance risk stratification of MARCE for patients with AMI and CKD. These models might aid in stratifying risk and choosing appropriate therapeutic strategies in the management of patients with AMI and CKD.